State Street Corp Purchases 50,597 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

State Street Corp increased its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 1.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 3,540,791 shares of the company’s stock after purchasing an additional 50,597 shares during the quarter. State Street Corp owned 4.12% of Pediatrix Medical Group worth $41,038,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in MD. Nisa Investment Advisors LLC increased its holdings in Pediatrix Medical Group by 47.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company’s stock worth $36,000 after purchasing an additional 1,524 shares during the period. Innealta Capital LLC acquired a new stake in Pediatrix Medical Group in the second quarter valued at approximately $33,000. nVerses Capital LLC purchased a new position in Pediatrix Medical Group during the 2nd quarter worth $31,000. Ballentine Partners LLC purchased a new position in shares of Pediatrix Medical Group in the 2nd quarter valued at approximately $132,000. Finally, Texas Permanent School Fund Corp lifted its stake in shares of Pediatrix Medical Group by 29.6% during the second quarter. Texas Permanent School Fund Corp now owns 93,367 shares of the company’s stock worth $705,000 after buying an additional 21,351 shares during the period. 97.71% of the stock is currently owned by institutional investors.

Insider Transactions at Pediatrix Medical Group

In other news, Director Mark S. Ordan sold 27,600 shares of the stock in a transaction that occurred on Wednesday, November 13th. The shares were sold at an average price of $15.35, for a total value of $423,660.00. Following the completion of the sale, the director now owns 138,683 shares of the company’s stock, valued at $2,128,784.05. This represents a 16.60 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Mary Ann E. Moore sold 8,108 shares of Pediatrix Medical Group stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $16.00, for a total transaction of $129,728.00. Following the sale, the executive vice president now directly owns 135,810 shares in the company, valued at approximately $2,172,960. The trade was a 5.63 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.00% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on MD shares. Mizuho increased their price target on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a report on Tuesday, November 19th. UBS Group lifted their price objective on shares of Pediatrix Medical Group from $10.50 to $16.50 and gave the company a “neutral” rating in a report on Tuesday, November 5th. Jefferies Financial Group boosted their price objective on Pediatrix Medical Group from $14.00 to $18.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Macquarie assumed coverage on shares of Pediatrix Medical Group in a research report on Monday, December 16th. They set an “outperform” rating and a $18.00 price objective for the company. Finally, Truist Financial upped their price target on shares of Pediatrix Medical Group from $13.00 to $16.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Five equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $16.42.

Pediatrix Medical Group Stock Down 1.1 %

Shares of NYSE MD opened at $14.09 on Friday. The stock has a market cap of $1.21 billion, a PE ratio of -4.60, a P/E/G ratio of 2.00 and a beta of 1.57. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.83. Pediatrix Medical Group, Inc. has a 12-month low of $6.62 and a 12-month high of $16.41. The company has a 50-day moving average of $14.15 and a 200 day moving average of $10.92.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Friday, November 1st. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. Pediatrix Medical Group had a positive return on equity of 12.79% and a negative net margin of 12.65%. The business had revenue of $511.20 million during the quarter, compared to analyst estimates of $498.87 million. During the same period in the prior year, the business earned $0.29 earnings per share. The business’s revenue was up .9% compared to the same quarter last year. As a group, sell-side analysts predict that Pediatrix Medical Group, Inc. will post 1.26 EPS for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.